Dean Shannon, Milford US
Dean Shannon, Milford, MA US
Patent application number | Description | Published |
---|---|---|
20100234423 | TRIAZOLOTHIADIAZOLE INHIBITOR OF C-MET PROTEIN KINASE - The present invention relates to compound 1, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising Compound 1 and methods of using the compositions in the treatment of proliferative disorders. | 09-16-2010 |
20110136789 | C-MET PROTEIN KINASE INHIBITORS - The present invention relates to compounds of formula I useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative disorders. | 06-09-2011 |
20110207774 | TRIAZOLOTHIADIAZOLE INHIBITOR OF C-MET PROTEIN KINASE - The present invention relates to compound 1, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising Compound 1 and methods of using the compositions in the treatment of proliferative disorders. | 08-25-2011 |
20110301195 | TRIAZOLOTHIADIAZOLE INHIBITOR OF C-MET PROTEIN KINASE - The present invention relates to compound 1, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising Compound 1 and methods of using the compositions in the treatment of proliferative disorders. | 12-08-2011 |
20120184564 | SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[6-FLUORO-5-[2-(1-HYDROXY-1-METHYL-ETHYL)PYRIMIDIN-5-YL]-7-- (TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL]UREA - The present application is directed to solid forms of compounds of formula I: | 07-19-2012 |
20120184741 | SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[5-[2-(1-HYDROXY-METHYL-ETHYL)PYRIMIDIN-5-YL]-7-(TETRAHYDRO- FURAN-2-YL)-1H-BENZIMIDAZOL-2-YL]UREA - The present application is directed to solid forms of compounds of formula (I): | 07-19-2012 |
20120184742 | PROCESS OF MAKING GYRASE AND TOPOISOMERASE IV INHIBITORS - The present application is directed to compounds, intermediates and methods for preparing compounds of formula (I) | 07-19-2012 |
20130261305 | PROCESS OF MAKING GYRASE AND TOPOISOMERASE INHIBITORS - The present application is directed to compounds, intermediates and methods for preparing compounds of formula (I) | 10-03-2013 |
20130267540 | SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[6-FLUORO-5-[2-(1-HYDROXY-1-METHYL-ETHYL)PYRIMIDIN-5-YL]-7-- (TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL]UREA - The present application is directed to solid forms of compounds of formula I: | 10-10-2013 |
20130317222 | SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[5-[2-(1-HYDROXY-1-METHYL-ETHYL)PYRIMIDIN-5-YL]-7-(TETRAHYD- ROFURAN-2-YL]-1H-BENZIMIDAZOL-2-YL]UREA - The present application is directed to solid forms of compounds of formula (I): | 11-28-2013 |